Vitamin D receptor gene polymorphism is associated with multiple myeloma

J Cell Biochem. 2020 Jan;121(1):224-230. doi: 10.1002/jcb.29135. Epub 2019 Jun 6.

Abstract

Objectives: The aim of this study was to explore the Vitamin D receptor (VDR) gene polymorphism and its association with multiple myeloma (MM) development.

Methods: The peripheral blood of 40 MM cases and 84 healthy controls were collected. Polymerase chain reaction (PCR) and DNA sequencing were applied to detect VDR gene polymorphism (including: FokI, BsmI, ApaI, and TaqI). SHESIS biological information software was used to analyze genotypes, alleles, linkage disequilibrium (LD), haplotype distribution, and their association with MM.

Results: Compared with controls, the MM group had a significantly higher frequency of the A allele in BsmI site (8.7% vs 2.4%) and C allele in the TaqI site (10.5% vs 3.6%). These two alleles were closely associated with an increased risk of MM (P = .025; P = .030). The highly rare genotypes (BsmI-AA and TaqI-CC) were found in one patient with MM.

Conclusion: VDR gene polymorphisms may be a molecular marker of MM risk.

Keywords: SNP; gene polymorphism; multiple myeloma; vitamin D receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alleles
  • Female
  • Gene Expression Regulation, Neoplastic*
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Genotype
  • Haplotypes
  • Humans
  • Linkage Disequilibrium
  • Male
  • Middle Aged
  • Multiple Myeloma / genetics*
  • Polymerase Chain Reaction
  • Polymorphism, Genetic*
  • Receptors, Calcitriol / genetics*
  • Sequence Analysis, DNA

Substances

  • Receptors, Calcitriol
  • VDR protein, human